[
  {
    "title": "Building A $1,000,000 Dividend Portfolio: A Strategy For Growth, Income And Risk Management",
    "published": 1740679200,
    "day_prices": {
      "2025-02-27T14:30:00+00:00": 162.30999755859375,
      "2025-02-27T15:30:00+00:00": 163.06069946289062,
      "2025-02-27T16:30:00+00:00": 162.8000030517578,
      "2025-02-27T17:30:00+00:00": 162.44000244140625,
      "2025-02-27T18:30:00+00:00": 162.8800048828125,
      "2025-02-27T19:30:00+00:00": 163.13999938964844,
      "2025-02-27T20:30:00+00:00": 163.3350067138672
    },
    "sentiment": 0.8758477568626404
  },
  {
    "title": "Johnson & Johnson (JNJ): One of the Best Vaccine Stocks to Buy According to Hedge Funds",
    "published": 1740663513,
    "day_prices": {
      "2025-02-27T14:30:00+00:00": 162.30999755859375,
      "2025-02-27T15:30:00+00:00": 163.06069946289062,
      "2025-02-27T16:30:00+00:00": 162.8000030517578,
      "2025-02-27T17:30:00+00:00": 162.44000244140625,
      "2025-02-27T18:30:00+00:00": 162.8800048828125,
      "2025-02-27T19:30:00+00:00": 163.13999938964844,
      "2025-02-27T20:30:00+00:00": 163.3350067138672
    },
    "sentiment": 0.5851094126701355
  },
  {
    "title": "Why Novartis Remains A 'Buy' After Beating Expectations Again",
    "published": 1740650974,
    "day_prices": {
      "2025-02-27T14:30:00+00:00": 162.30999755859375,
      "2025-02-27T15:30:00+00:00": 163.06069946289062,
      "2025-02-27T16:30:00+00:00": 162.8000030517578,
      "2025-02-27T17:30:00+00:00": 162.44000244140625,
      "2025-02-27T18:30:00+00:00": 162.8800048828125,
      "2025-02-27T19:30:00+00:00": 163.13999938964844,
      "2025-02-27T20:30:00+00:00": 163.3350067138672
    },
    "sentiment": 0.7849723100662231
  },
  {
    "title": "Is Johnson & Johnson (JNJ) the Cheap Global Stock to Buy Right Now?",
    "published": 1740602254,
    "day_prices": {
      "2025-02-26T14:30:00+00:00": 165.0800018310547,
      "2025-02-26T15:30:00+00:00": 164.02999877929688,
      "2025-02-26T16:30:00+00:00": 163.49000549316406,
      "2025-02-26T17:30:00+00:00": 163.19000244140625,
      "2025-02-26T18:30:00+00:00": 163.1199951171875,
      "2025-02-26T19:30:00+00:00": 163.72000122070312,
      "2025-02-26T20:30:00+00:00": 162.74000549316406
    },
    "sentiment": 0.9042016863822937
  },
  {
    "title": "Johnson & Johnson (JNJ) Could Be a Great Choice",
    "published": 1740588307,
    "day_prices": {
      "2025-02-26T14:30:00+00:00": 165.0800018310547,
      "2025-02-26T15:30:00+00:00": 164.02999877929688,
      "2025-02-26T16:30:00+00:00": 163.49000549316406,
      "2025-02-26T17:30:00+00:00": 163.19000244140625,
      "2025-02-26T18:30:00+00:00": 163.1199951171875,
      "2025-02-26T19:30:00+00:00": 163.72000122070312,
      "2025-02-26T20:30:00+00:00": 162.74000549316406
    },
    "sentiment": 0.6627047657966614
  },
  {
    "title": "Is Johnson & Johnson (JNJ) the Best Retirement Stock to Buy According to Hedge Funds?",
    "published": 1740562756,
    "day_prices": {
      "2025-02-26T14:30:00+00:00": 165.0800018310547,
      "2025-02-26T15:30:00+00:00": 164.02999877929688,
      "2025-02-26T16:30:00+00:00": 163.49000549316406,
      "2025-02-26T17:30:00+00:00": 163.19000244140625,
      "2025-02-26T18:30:00+00:00": 163.1199951171875,
      "2025-02-26T19:30:00+00:00": 163.72000122070312,
      "2025-02-26T20:30:00+00:00": 162.74000549316406
    },
    "sentiment": 0.895054280757904
  },
  {
    "title": "J&J sues Samsung Bioepis over \u2018surreptitious\u2019 breach of Stelara biosimilar contract",
    "published": 1740526952,
    "day_prices": {
      "2025-02-25T14:30:00+00:00": 164.10000610351562,
      "2025-02-25T15:30:00+00:00": 165.8300018310547,
      "2025-02-25T16:30:00+00:00": 165.7899932861328,
      "2025-02-25T17:30:00+00:00": 165.8300018310547,
      "2025-02-25T18:30:00+00:00": 165.8300018310547,
      "2025-02-25T19:30:00+00:00": 165.35499572753906,
      "2025-02-25T20:30:00+00:00": 165.77000427246094
    },
    "sentiment": 0.9331853985786438
  },
  {
    "title": "Healthcare Stocks Should Be Hurting. How the Sector Became This Year\u2019s Top Performer.",
    "published": 1740500160,
    "day_prices": {
      "2025-02-25T14:30:00+00:00": 164.10000610351562,
      "2025-02-25T15:30:00+00:00": 165.8300018310547,
      "2025-02-25T16:30:00+00:00": 165.7899932861328,
      "2025-02-25T17:30:00+00:00": 165.8300018310547,
      "2025-02-25T18:30:00+00:00": 165.8300018310547,
      "2025-02-25T19:30:00+00:00": 165.35499572753906,
      "2025-02-25T20:30:00+00:00": 165.77000427246094
    },
    "sentiment": 0.9493907690048218
  },
  {
    "title": "J&J\u2019s potential neurovascular exit: implications for market dynamics",
    "published": 1740483536,
    "day_prices": {
      "2025-02-25T14:30:00+00:00": 164.10000610351562,
      "2025-02-25T15:30:00+00:00": 165.8300018310547,
      "2025-02-25T16:30:00+00:00": 165.7899932861328,
      "2025-02-25T17:30:00+00:00": 165.8300018310547,
      "2025-02-25T18:30:00+00:00": 165.8300018310547,
      "2025-02-25T19:30:00+00:00": 165.35499572753906,
      "2025-02-25T20:30:00+00:00": 165.77000427246094
    },
    "sentiment": 0.7414201498031616
  },
  {
    "title": "Hartford Equity Income Fund Q4 2024 Commentary",
    "published": 1740435780,
    "day_prices": {
      "2025-02-24T14:30:00+00:00": 162.67999267578125,
      "2025-02-24T15:30:00+00:00": 164.11000061035156,
      "2025-02-24T16:30:00+00:00": 163.8699951171875,
      "2025-02-24T17:30:00+00:00": 163.7100067138672,
      "2025-02-24T18:30:00+00:00": 163.39999389648438,
      "2025-02-24T19:30:00+00:00": 163.91900634765625,
      "2025-02-24T20:30:00+00:00": 163.9550018310547
    },
    "sentiment": 0.9411500692367554
  },
  {
    "title": "5 Stocks in the Dow ETF That Survived the Worst Week Since October",
    "published": 1740407400,
    "day_prices": {
      "2025-02-24T14:30:00+00:00": 162.67999267578125,
      "2025-02-24T15:30:00+00:00": 164.11000061035156,
      "2025-02-24T16:30:00+00:00": 163.8699951171875,
      "2025-02-24T17:30:00+00:00": 163.7100067138672,
      "2025-02-24T18:30:00+00:00": 163.39999389648438,
      "2025-02-24T19:30:00+00:00": 163.91900634765625,
      "2025-02-24T20:30:00+00:00": 163.9550018310547
    },
    "sentiment": 0.905558168888092
  },
  {
    "title": "LVHD: Seeking Low Volatility In High Dividends With Average Result",
    "published": 1740404809,
    "day_prices": {
      "2025-02-24T14:30:00+00:00": 162.67999267578125,
      "2025-02-24T15:30:00+00:00": 164.11000061035156,
      "2025-02-24T16:30:00+00:00": 163.8699951171875,
      "2025-02-24T17:30:00+00:00": 163.7100067138672,
      "2025-02-24T18:30:00+00:00": 163.39999389648438,
      "2025-02-24T19:30:00+00:00": 163.91900634765625,
      "2025-02-24T20:30:00+00:00": 163.9550018310547
    },
    "sentiment": 0.5942657589912415
  },
  {
    "title": "TREMFYA (guselkumab) subcutaneous (SC) induction data support potential to be the first and only in its class to offer the option of both intravenous and SC induction therapy in ulcerative colitis",
    "published": 1740395299,
    "day_prices": {
      "2025-02-24T14:30:00+00:00": 162.67999267578125,
      "2025-02-24T15:30:00+00:00": 164.11000061035156,
      "2025-02-24T16:30:00+00:00": 163.8699951171875,
      "2025-02-24T17:30:00+00:00": 163.7100067138672,
      "2025-02-24T18:30:00+00:00": 163.39999389648438,
      "2025-02-24T19:30:00+00:00": 163.91900634765625,
      "2025-02-24T20:30:00+00:00": 163.9550018310547
    },
    "sentiment": 0.573171854019165
  },
  {
    "title": "Hartford Balanced Income Fund Q4 2024 Commentary",
    "published": 1740378240,
    "day_prices": {
      "2025-02-24T14:30:00+00:00": 162.67999267578125,
      "2025-02-24T15:30:00+00:00": 164.11000061035156,
      "2025-02-24T16:30:00+00:00": 163.8699951171875,
      "2025-02-24T17:30:00+00:00": 163.7100067138672,
      "2025-02-24T18:30:00+00:00": 163.39999389648438,
      "2025-02-24T19:30:00+00:00": 163.91900634765625,
      "2025-02-24T20:30:00+00:00": 163.9550018310547
    },
    "sentiment": 0.9232373237609863
  },
  {
    "title": "Johnson & Johnson (JNJ): Among the Best Performing Dow Stocks So Far in 2025",
    "published": 1740340924,
    "day_prices": {},
    "sentiment": 0.9432618618011475
  },
  {
    "title": "European Banks Swarm Dollar Market For AT1 Debt: Credit Weekly",
    "published": 1740254400,
    "day_prices": {},
    "sentiment": 0.896443784236908
  },
  {
    "title": "Johnson & Johnson (JNJ) Up 8.9% Since Last Earnings Report: Can It Continue?",
    "published": 1740155425,
    "day_prices": {
      "2025-02-21T14:30:00+00:00": 159.8800048828125,
      "2025-02-21T15:30:00+00:00": 160.91000366210938,
      "2025-02-21T16:30:00+00:00": 161.66600036621094,
      "2025-02-21T17:30:00+00:00": 161.72950744628906,
      "2025-02-21T18:30:00+00:00": 162.44000244140625,
      "2025-02-21T19:30:00+00:00": 162.89959716796875,
      "2025-02-21T20:30:00+00:00": 162.6199951171875
    },
    "sentiment": 0.9518827795982361
  },
  {
    "title": "Is Johnson & Johnson (JNJ) the Best Non-Tech Stock to Buy Now for Long Term?",
    "published": 1740142363,
    "day_prices": {
      "2025-02-21T14:30:00+00:00": 159.8800048828125,
      "2025-02-21T15:30:00+00:00": 160.91000366210938,
      "2025-02-21T16:30:00+00:00": 161.66600036621094,
      "2025-02-21T17:30:00+00:00": 161.72950744628906,
      "2025-02-21T18:30:00+00:00": 162.44000244140625,
      "2025-02-21T19:30:00+00:00": 162.89959716796875,
      "2025-02-21T20:30:00+00:00": 162.6199951171875
    },
    "sentiment": 0.813300609588623
  },
  {
    "title": "Allspring Growth Fund Q4 2024 Commentary",
    "published": 1740116700,
    "day_prices": {
      "2025-02-21T14:30:00+00:00": 159.8800048828125,
      "2025-02-21T15:30:00+00:00": 160.91000366210938,
      "2025-02-21T16:30:00+00:00": 161.66600036621094,
      "2025-02-21T17:30:00+00:00": 161.72950744628906,
      "2025-02-21T18:30:00+00:00": 162.44000244140625,
      "2025-02-21T19:30:00+00:00": 162.89959716796875,
      "2025-02-21T20:30:00+00:00": 162.6199951171875
    },
    "sentiment": 0.930094838142395
  },
  {
    "title": "Madison Dividend Income Fund Q4 2024 Investment Strategy Letter",
    "published": 1740058320,
    "day_prices": {
      "2025-02-20T14:30:00+00:00": 156.9499969482422,
      "2025-02-20T15:30:00+00:00": 159.30499267578125,
      "2025-02-20T16:30:00+00:00": 159.66000366210938,
      "2025-02-20T17:30:00+00:00": 159.4199981689453,
      "2025-02-20T18:30:00+00:00": 159.36000061035156,
      "2025-02-20T19:30:00+00:00": 159.4199981689453,
      "2025-02-20T20:30:00+00:00": 159.3800048828125
    },
    "sentiment": 0.9382883906364441
  },
  {
    "title": "My Dividend Stock Portfolio: New January Dividend Record - 100 Holdings With 14 Buys",
    "published": 1739952600,
    "day_prices": {
      "2025-02-19T14:30:00+00:00": 155.0,
      "2025-02-19T15:30:00+00:00": 156.77999877929688,
      "2025-02-19T16:30:00+00:00": 157.2449951171875,
      "2025-02-19T17:30:00+00:00": 157.1300048828125,
      "2025-02-19T18:30:00+00:00": 157.72000122070312,
      "2025-02-19T19:30:00+00:00": 157.8000030517578,
      "2025-02-19T20:30:00+00:00": 158.06500244140625
    },
    "sentiment": 0.8562964797019958
  },
  {
    "title": "Johnson & Johnson Goes to Trial on Third Talc Bankruptcy Plan",
    "published": 1739899320,
    "day_prices": {
      "2025-02-18T14:30:00+00:00": 154.13999938964844,
      "2025-02-18T15:30:00+00:00": 154.75,
      "2025-02-18T16:30:00+00:00": 154.64999389648438,
      "2025-02-18T17:30:00+00:00": 154.8350067138672,
      "2025-02-18T18:30:00+00:00": 154.86000061035156,
      "2025-02-18T19:30:00+00:00": 154.69500732421875,
      "2025-02-18T20:30:00+00:00": 155.27569580078125
    },
    "sentiment": 0.6581485867500305
  },
  {
    "title": "Genmab: Positive 2025 Outlook, Johnson & Johnson's Decision Coming Soon",
    "published": 1739845553,
    "day_prices": {
      "2025-02-18T14:30:00+00:00": 154.13999938964844,
      "2025-02-18T15:30:00+00:00": 154.75,
      "2025-02-18T16:30:00+00:00": 154.64999389648438,
      "2025-02-18T17:30:00+00:00": 154.8350067138672,
      "2025-02-18T18:30:00+00:00": 154.86000061035156,
      "2025-02-18T19:30:00+00:00": 154.69500732421875,
      "2025-02-18T20:30:00+00:00": 155.27569580078125
    },
    "sentiment": 0.92885822057724
  },
  {
    "title": "Looming Challenges, But Kenvue Could Become A Compelling Dividend Growth Stock Beyond 2025",
    "published": 1739800800,
    "day_prices": {},
    "sentiment": 0.9204014539718628
  },
  {
    "title": "Globus Medical: Some Caution After Its Deal For Nevro",
    "published": 1739689537,
    "day_prices": {},
    "sentiment": 0.7767051458358765
  },
  {
    "title": "Walmart, Alibaba, Medtronic To Reports Earnings During Holiday-Shortened Week",
    "published": 1739617200,
    "day_prices": {},
    "sentiment": 0.546232283115387
  },
  {
    "title": "Tracking Jeremy Grantham's GMO Capital Portfolio - Q4 2024 Update",
    "published": 1739486426,
    "day_prices": {
      "2025-02-13T14:30:00+00:00": 155.25999450683594,
      "2025-02-13T15:30:00+00:00": 155.96499633789062,
      "2025-02-13T16:30:00+00:00": 156.8800048828125,
      "2025-02-13T17:30:00+00:00": 157.17999267578125,
      "2025-02-13T18:30:00+00:00": 157.3000030517578,
      "2025-02-13T19:30:00+00:00": 157.8350067138672,
      "2025-02-13T20:30:00+00:00": 157.5399932861328
    },
    "sentiment": 0.9428676962852478
  },
  {
    "title": "Kiniksa Pharmaceuticals: Strong Improvement In Arcalyst Revenue, But Risks Remain",
    "published": 1739468968,
    "day_prices": {
      "2025-02-13T14:30:00+00:00": 155.25999450683594,
      "2025-02-13T15:30:00+00:00": 155.96499633789062,
      "2025-02-13T16:30:00+00:00": 156.8800048828125,
      "2025-02-13T17:30:00+00:00": 157.17999267578125,
      "2025-02-13T18:30:00+00:00": 157.3000030517578,
      "2025-02-13T19:30:00+00:00": 157.8350067138672,
      "2025-02-13T20:30:00+00:00": 157.5399932861328
    },
    "sentiment": 0.8951048851013184
  },
  {
    "title": "Tracking Tweedy Browne Portfolio - Q4 2024 Update",
    "published": 1739398529,
    "day_prices": {
      "2025-02-12T14:30:00+00:00": 155.27000427246094,
      "2025-02-12T15:30:00+00:00": 154.5500030517578,
      "2025-02-12T16:30:00+00:00": 154.52000427246094,
      "2025-02-12T17:30:00+00:00": 155.1199951171875,
      "2025-02-12T18:30:00+00:00": 154.66000366210938,
      "2025-02-12T19:30:00+00:00": 154.86500549316406,
      "2025-02-12T20:30:00+00:00": 155.4199981689453
    },
    "sentiment": 0.9414435029029846
  },
  {
    "title": "IGA: Good Diversification And Fully-Covered Distribution (Rating Upgrade)",
    "published": 1739377566,
    "day_prices": {
      "2025-02-12T14:30:00+00:00": 155.27000427246094,
      "2025-02-12T15:30:00+00:00": 154.5500030517578,
      "2025-02-12T16:30:00+00:00": 154.52000427246094,
      "2025-02-12T17:30:00+00:00": 155.1199951171875,
      "2025-02-12T18:30:00+00:00": 154.66000366210938,
      "2025-02-12T19:30:00+00:00": 154.86500549316406,
      "2025-02-12T20:30:00+00:00": 155.4199981689453
    },
    "sentiment": 0.8406534194946289
  },
  {
    "title": "Axsome Settling Teva Patent Litigation Is Another Positive Catalyst -- Upgrade",
    "published": 1739294443,
    "day_prices": {
      "2025-02-11T14:30:00+00:00": 154.11000061035156,
      "2025-02-11T15:30:00+00:00": 155.25999450683594,
      "2025-02-11T16:30:00+00:00": 155.64999389648438,
      "2025-02-11T17:30:00+00:00": 156.1199951171875,
      "2025-02-11T18:30:00+00:00": 155.89010620117188,
      "2025-02-11T19:30:00+00:00": 155.9600067138672,
      "2025-02-11T20:30:00+00:00": 156.25999450683594
    },
    "sentiment": 0.6216502785682678
  },
  {
    "title": "Invesco Diversified Dividend Fund Q4 2024 Commentary",
    "published": 1739274240,
    "day_prices": {
      "2025-02-11T14:30:00+00:00": 154.11000061035156,
      "2025-02-11T15:30:00+00:00": 155.25999450683594,
      "2025-02-11T16:30:00+00:00": 155.64999389648438,
      "2025-02-11T17:30:00+00:00": 156.1199951171875,
      "2025-02-11T18:30:00+00:00": 155.89010620117188,
      "2025-02-11T19:30:00+00:00": 155.9600067138672,
      "2025-02-11T20:30:00+00:00": 156.25999450683594
    },
    "sentiment": 0.9036495685577393
  },
  {
    "title": "Steady M&A Deals To Begin 2025, Disappointing IPOs So Far",
    "published": 1739238000,
    "day_prices": {
      "2025-02-11T14:30:00+00:00": 154.11000061035156,
      "2025-02-11T15:30:00+00:00": 155.25999450683594,
      "2025-02-11T16:30:00+00:00": 155.64999389648438,
      "2025-02-11T17:30:00+00:00": 156.1199951171875,
      "2025-02-11T18:30:00+00:00": 155.89010620117188,
      "2025-02-11T19:30:00+00:00": 155.9600067138672,
      "2025-02-11T20:30:00+00:00": 156.25999450683594
    },
    "sentiment": 0.969183087348938
  },
  {
    "title": "Fidelity Balanced Fund Q4 2024 Review",
    "published": 1739166420,
    "day_prices": {
      "2025-02-10T14:30:00+00:00": 153.61000061035156,
      "2025-02-10T15:30:00+00:00": 152.9600067138672,
      "2025-02-10T16:30:00+00:00": 153.2740020751953,
      "2025-02-10T17:30:00+00:00": 153.50999450683594,
      "2025-02-10T18:30:00+00:00": 153.61000061035156,
      "2025-02-10T19:30:00+00:00": 153.9250030517578,
      "2025-02-10T20:30:00+00:00": 153.9499969482422
    },
    "sentiment": 0.9342239499092102
  },
  {
    "title": "Kenvue: An Intriguing Turnaround",
    "published": 1739145811,
    "day_prices": {
      "2025-02-10T14:30:00+00:00": 153.61000061035156,
      "2025-02-10T15:30:00+00:00": 152.9600067138672,
      "2025-02-10T16:30:00+00:00": 153.2740020751953,
      "2025-02-10T17:30:00+00:00": 153.50999450683594,
      "2025-02-10T18:30:00+00:00": 153.61000061035156,
      "2025-02-10T19:30:00+00:00": 153.9250030517578,
      "2025-02-10T20:30:00+00:00": 153.9499969482422
    },
    "sentiment": 0.6610458493232727
  },
  {
    "title": "Our Real-Life Market-Beating U.S. Stock Portfolio, Ten Years After",
    "published": 1738941899,
    "day_prices": {
      "2025-02-07T14:30:00+00:00": 153.52999877929688,
      "2025-02-07T15:30:00+00:00": 153.9250030517578,
      "2025-02-07T16:30:00+00:00": 153.6699981689453,
      "2025-02-07T17:30:00+00:00": 153.97000122070312,
      "2025-02-07T18:30:00+00:00": 154.0050048828125,
      "2025-02-07T19:30:00+00:00": 153.86000061035156,
      "2025-02-07T20:30:00+00:00": 153.6300048828125
    },
    "sentiment": 0.5566059350967407
  },
  {
    "title": "Franklin Equity Income Fund Q4 2024 Commentary",
    "published": 1738834500,
    "day_prices": {
      "2025-02-06T14:30:00+00:00": 154.7899932861328,
      "2025-02-06T15:30:00+00:00": 154.0500030517578,
      "2025-02-06T16:30:00+00:00": 154.47999572753906,
      "2025-02-06T17:30:00+00:00": 153.97999572753906,
      "2025-02-06T18:30:00+00:00": 154.0500030517578,
      "2025-02-06T19:30:00+00:00": 153.92999267578125,
      "2025-02-06T20:30:00+00:00": 153.7100067138672
    },
    "sentiment": 0.9403002262115479
  },
  {
    "title": "Starboard Launches Proxy Fight at Kenvue",
    "published": 1738746360,
    "day_prices": {
      "2025-02-05T14:30:00+00:00": 153.82000732421875,
      "2025-02-05T15:30:00+00:00": 153.97000122070312,
      "2025-02-05T16:30:00+00:00": 153.82000732421875,
      "2025-02-05T17:30:00+00:00": 153.82000732421875,
      "2025-02-05T18:30:00+00:00": 154.05999755859375,
      "2025-02-05T19:30:00+00:00": 154.4967041015625,
      "2025-02-05T20:30:00+00:00": 154.47000122070312
    },
    "sentiment": 0.49848800897598267
  },
  {
    "title": "J.P. Morgan Healthcare Conference 2025: Healthcare's Roadmap For The Year Ahead",
    "published": 1738720500,
    "day_prices": {
      "2025-02-05T14:30:00+00:00": 153.82000732421875,
      "2025-02-05T15:30:00+00:00": 153.97000122070312,
      "2025-02-05T16:30:00+00:00": 153.82000732421875,
      "2025-02-05T17:30:00+00:00": 153.82000732421875,
      "2025-02-05T18:30:00+00:00": 154.05999755859375,
      "2025-02-05T19:30:00+00:00": 154.4967041015625,
      "2025-02-05T20:30:00+00:00": 154.47000122070312
    },
    "sentiment": 0.866245687007904
  },
  {
    "title": "Federal District Court Dismisses Another Case Regarding The Cost Of Prescription Drug Coverage",
    "published": 1738645809,
    "day_prices": {
      "2025-02-04T14:30:00+00:00": 151.36000061035156,
      "2025-02-04T15:30:00+00:00": 152.47500610351562,
      "2025-02-04T16:30:00+00:00": 153.32009887695312,
      "2025-02-04T17:30:00+00:00": 154.0800018310547,
      "2025-02-04T18:30:00+00:00": 153.44920349121094,
      "2025-02-04T19:30:00+00:00": 154.0030059814453,
      "2025-02-04T20:30:00+00:00": 153.9499969482422
    },
    "sentiment": 0.9253843426704407
  },
  {
    "title": "J&J: CHMP gives the green light for subcutaneous Rybrevant",
    "published": 1738569317,
    "day_prices": {
      "2025-02-03T14:30:00+00:00": 152.0,
      "2025-02-03T15:30:00+00:00": 151.66000366210938,
      "2025-02-03T16:30:00+00:00": 151.75999450683594,
      "2025-02-03T17:30:00+00:00": 151.97000122070312,
      "2025-02-03T18:30:00+00:00": 151.80999755859375,
      "2025-02-03T19:30:00+00:00": 152.0,
      "2025-02-03T20:30:00+00:00": 151.8000030517578
    },
    "sentiment": 0.5677398443222046
  },
  {
    "title": "ORIC Pharmaceuticals: Too Early To Commit, Despite Some Good Early Data",
    "published": 1738472729,
    "day_prices": {},
    "sentiment": 0.5866532325744629
  },
  {
    "title": "Eli Lilly Vs. Novo Nordisk: Which Is The Better Bargain For Investors",
    "published": 1743310800,
    "day_prices": {},
    "sentiment": 0.735475480556488
  },
  {
    "title": "3 Relatively Safe Stocks to Buy Right Now",
    "published": 1743245100,
    "day_prices": {},
    "sentiment": 0.8660998344421387
  },
  {
    "title": "Sector Update: Health Care Stocks Softer Late Afternoon",
    "published": 1743191733,
    "day_prices": {
      "2025-03-28T13:30:00+00:00": 163.58999633789062,
      "2025-03-28T14:30:00+00:00": 164.0500030517578,
      "2025-03-28T15:30:00+00:00": 164.29969787597656,
      "2025-03-28T16:30:00+00:00": 164.0800018310547,
      "2025-03-28T17:30:00+00:00": 164.30999755859375,
      "2025-03-28T18:30:00+00:00": 163.67799377441406,
      "2025-03-28T19:30:00+00:00": 163.84500122070312
    },
    "sentiment": 0.8598366975784302
  },
  {
    "title": "Johnson & Johnson unit ordered to pay $1.64 billion in HIV drug marketing case",
    "published": 1743178719,
    "day_prices": {
      "2025-03-28T13:30:00+00:00": 163.58999633789062,
      "2025-03-28T14:30:00+00:00": 164.0500030517578,
      "2025-03-28T15:30:00+00:00": 164.29969787597656,
      "2025-03-28T16:30:00+00:00": 164.0800018310547,
      "2025-03-28T17:30:00+00:00": 164.30999755859375,
      "2025-03-28T18:30:00+00:00": 163.67799377441406,
      "2025-03-28T19:30:00+00:00": 163.84500122070312
    },
    "sentiment": 0.9608162641525269
  },
  {
    "title": "Johnson & Johnson MedTech to Highlight Latest Advancements in Heart Disease Treatment with Impella at ACC.25",
    "published": 1743154890,
    "day_prices": {
      "2025-03-28T13:30:00+00:00": 163.58999633789062,
      "2025-03-28T14:30:00+00:00": 164.0500030517578,
      "2025-03-28T15:30:00+00:00": 164.29969787597656,
      "2025-03-28T16:30:00+00:00": 164.0800018310547,
      "2025-03-28T17:30:00+00:00": 164.30999755859375,
      "2025-03-28T18:30:00+00:00": 163.67799377441406,
      "2025-03-28T19:30:00+00:00": 163.84500122070312
    },
    "sentiment": 0.5501490831375122
  },
  {
    "title": "Tracking Cliff Asness' AQR Capital Management 13F Portfolio - Q4 2024 Update",
    "published": 1743108470,
    "day_prices": {
      "2025-03-27T13:30:00+00:00": 162.35000610351562,
      "2025-03-27T14:30:00+00:00": 163.1699981689453,
      "2025-03-27T15:30:00+00:00": 163.80499267578125,
      "2025-03-27T16:30:00+00:00": 163.47000122070312,
      "2025-03-27T17:30:00+00:00": 162.97000122070312,
      "2025-03-27T18:30:00+00:00": 163.1699981689453,
      "2025-03-27T19:30:00+00:00": 163.50999450683594
    },
    "sentiment": 0.9391833543777466
  },
  {
    "title": "J&J says Rybrevant/Lazcluze outperforms osimertinib OS in Phase 3 study",
    "published": 1743090609,
    "day_prices": {
      "2025-03-27T13:30:00+00:00": 162.35000610351562,
      "2025-03-27T14:30:00+00:00": 163.1699981689453,
      "2025-03-27T15:30:00+00:00": 163.80499267578125,
      "2025-03-27T16:30:00+00:00": 163.47000122070312,
      "2025-03-27T17:30:00+00:00": 162.97000122070312,
      "2025-03-27T18:30:00+00:00": 163.1699981689453,
      "2025-03-27T19:30:00+00:00": 163.50999450683594
    },
    "sentiment": 0.9527356624603271
  },
  {
    "title": "Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know",
    "published": 1743080416,
    "day_prices": {
      "2025-03-27T13:30:00+00:00": 162.35000610351562,
      "2025-03-27T14:30:00+00:00": 163.1699981689453,
      "2025-03-27T15:30:00+00:00": 163.80499267578125,
      "2025-03-27T16:30:00+00:00": 163.47000122070312,
      "2025-03-27T17:30:00+00:00": 162.97000122070312,
      "2025-03-27T18:30:00+00:00": 163.1699981689453,
      "2025-03-27T19:30:00+00:00": 163.50999450683594
    },
    "sentiment": 0.943794310092926
  },
  {
    "title": "2 Recession-Proof Dividend Stocks to Buy and Hold",
    "published": 1743067500,
    "day_prices": {
      "2025-03-27T13:30:00+00:00": 162.35000610351562,
      "2025-03-27T14:30:00+00:00": 163.1699981689453,
      "2025-03-27T15:30:00+00:00": 163.80499267578125,
      "2025-03-27T16:30:00+00:00": 163.47000122070312,
      "2025-03-27T17:30:00+00:00": 162.97000122070312,
      "2025-03-27T18:30:00+00:00": 163.1699981689453,
      "2025-03-27T19:30:00+00:00": 163.50999450683594
    },
    "sentiment": 0.891663134098053
  },
  {
    "title": "Jim Cramer Highlights Johnson & Johnson (JNJ) as a Rare Winner Amid Market Sell-Off",
    "published": 1743018011,
    "day_prices": {
      "2025-03-26T13:30:00+00:00": 161.2100067138672,
      "2025-03-26T14:30:00+00:00": 162.11000061035156,
      "2025-03-26T15:30:00+00:00": 161.39999389648438,
      "2025-03-26T16:30:00+00:00": 161.82000732421875,
      "2025-03-26T17:30:00+00:00": 161.8699951171875,
      "2025-03-26T18:30:00+00:00": 162.05999755859375,
      "2025-03-26T19:30:00+00:00": 161.77000427246094
    },
    "sentiment": 0.9385221004486084
  },
  {
    "title": "Johnson & Johnson Reports Positive Data from Phase 3 Study of Lung Cancer Drug Candidate",
    "published": 1743007049,
    "day_prices": {
      "2025-03-26T13:30:00+00:00": 161.2100067138672,
      "2025-03-26T14:30:00+00:00": 162.11000061035156,
      "2025-03-26T15:30:00+00:00": 161.39999389648438,
      "2025-03-26T16:30:00+00:00": 161.82000732421875,
      "2025-03-26T17:30:00+00:00": 161.8699951171875,
      "2025-03-26T18:30:00+00:00": 162.05999755859375,
      "2025-03-26T19:30:00+00:00": 161.77000427246094
    },
    "sentiment": 0.9434110522270203
  },
  {
    "title": "Here's Why Johnson & Johnson (JNJ) is a Strong Value Stock",
    "published": 1742996410,
    "day_prices": {
      "2025-03-26T13:30:00+00:00": 161.2100067138672,
      "2025-03-26T14:30:00+00:00": 162.11000061035156,
      "2025-03-26T15:30:00+00:00": 161.39999389648438,
      "2025-03-26T16:30:00+00:00": 161.82000732421875,
      "2025-03-26T17:30:00+00:00": 161.8699951171875,
      "2025-03-26T18:30:00+00:00": 162.05999755859375,
      "2025-03-26T19:30:00+00:00": 161.77000427246094
    },
    "sentiment": 0.7713753581047058
  },
  {
    "title": "These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar",
    "published": 1742994005,
    "day_prices": {
      "2025-03-26T13:30:00+00:00": 161.2100067138672,
      "2025-03-26T14:30:00+00:00": 162.11000061035156,
      "2025-03-26T15:30:00+00:00": 161.39999389648438,
      "2025-03-26T16:30:00+00:00": 161.82000732421875,
      "2025-03-26T17:30:00+00:00": 161.8699951171875,
      "2025-03-26T18:30:00+00:00": 162.05999755859375,
      "2025-03-26T19:30:00+00:00": 161.77000427246094
    },
    "sentiment": 0.7639610767364502
  },
  {
    "title": "New nipocalimab data and real-world research at AAN 2025 highlight positive Phase 3 results and commitment to people living with generalized myasthenia gravis (gMG)",
    "published": 1742990580,
    "day_prices": {
      "2025-03-26T13:30:00+00:00": 161.2100067138672,
      "2025-03-26T14:30:00+00:00": 162.11000061035156,
      "2025-03-26T15:30:00+00:00": 161.39999389648438,
      "2025-03-26T16:30:00+00:00": 161.82000732421875,
      "2025-03-26T17:30:00+00:00": 161.8699951171875,
      "2025-03-26T18:30:00+00:00": 162.05999755859375,
      "2025-03-26T19:30:00+00:00": 161.77000427246094
    },
    "sentiment": 0.9244772791862488
  },
  {
    "title": "Wasatch Global Value Fund Q4 2024 Commentary",
    "published": 1742857560,
    "day_prices": {
      "2025-03-24T13:30:00+00:00": 162.83999633789062,
      "2025-03-24T14:30:00+00:00": 163.7550048828125,
      "2025-03-24T15:30:00+00:00": 163.47390747070312,
      "2025-03-24T16:30:00+00:00": 163.60000610351562,
      "2025-03-24T17:30:00+00:00": 163.17999267578125,
      "2025-03-24T18:30:00+00:00": 162.8800048828125,
      "2025-03-24T19:30:00+00:00": 163.3300018310547
    },
    "sentiment": 0.9379990696907043
  },
  {
    "title": "ACIU Stock Crashes 18.3% in a Month: Buy, Sell or Hold?",
    "published": 1742842800,
    "day_prices": {
      "2025-03-24T13:30:00+00:00": 162.83999633789062,
      "2025-03-24T14:30:00+00:00": 163.7550048828125,
      "2025-03-24T15:30:00+00:00": 163.47390747070312,
      "2025-03-24T16:30:00+00:00": 163.60000610351562,
      "2025-03-24T17:30:00+00:00": 163.17999267578125,
      "2025-03-24T18:30:00+00:00": 162.8800048828125,
      "2025-03-24T19:30:00+00:00": 163.3300018310547
    },
    "sentiment": 0.8570358157157898
  },
  {
    "title": "Is Johnson & Johnson (JNJ) The Best Healthcare Dividend Stock to Invest in?",
    "published": 1742822082,
    "day_prices": {
      "2025-03-24T13:30:00+00:00": 162.83999633789062,
      "2025-03-24T14:30:00+00:00": 163.7550048828125,
      "2025-03-24T15:30:00+00:00": 163.47390747070312,
      "2025-03-24T16:30:00+00:00": 163.60000610351562,
      "2025-03-24T17:30:00+00:00": 163.17999267578125,
      "2025-03-24T18:30:00+00:00": 162.8800048828125,
      "2025-03-24T19:30:00+00:00": 163.3300018310547
    },
    "sentiment": 0.7631819844245911
  },
  {
    "title": "Johnson & Johnson to break ground on new state-of-the-art biologics facility in North Carolina to deliver market-leading portfolio of transformational therapies",
    "published": 1742816842,
    "day_prices": {
      "2025-03-24T13:30:00+00:00": 162.83999633789062,
      "2025-03-24T14:30:00+00:00": 163.7550048828125,
      "2025-03-24T15:30:00+00:00": 163.47390747070312,
      "2025-03-24T16:30:00+00:00": 163.60000610351562,
      "2025-03-24T17:30:00+00:00": 163.17999267578125,
      "2025-03-24T18:30:00+00:00": 162.8800048828125,
      "2025-03-24T19:30:00+00:00": 163.3300018310547
    },
    "sentiment": 0.9244893193244934
  },
  {
    "title": "Spinoffs Can Pay Juicy Dividends. 6 Ones to Play.",
    "published": 1721831400,
    "day_prices": {
      "2024-07-24T13:30:00+00:00": 152.75999450683594,
      "2024-07-24T14:30:00+00:00": 153.75999450683594,
      "2024-07-24T15:30:00+00:00": 154.98500061035156,
      "2024-07-24T16:30:00+00:00": 156.02000427246094,
      "2024-07-24T17:30:00+00:00": 155.7100067138672,
      "2024-07-24T18:30:00+00:00": 155.8800048828125,
      "2024-07-24T19:30:00+00:00": 156.0399932861328
    },
    "sentiment": 0.9354683756828308
  },
  {
    "title": "Was Jim Cramer Right About Johnson & Johnson (JNJ)?",
    "published": 1742670386,
    "day_prices": {},
    "sentiment": 0.8034828305244446
  },
  {
    "title": "The Davenport Insider Buying Fund Q4 2024 Commentary",
    "published": 1742608200,
    "day_prices": {},
    "sentiment": 0.9354931116104126
  },
  {
    "title": "Johnson & Johnson is the latest pharma giant to court Trump with new investment plans",
    "published": 1742582460,
    "day_prices": {
      "2025-03-21T13:30:00+00:00": 163.0,
      "2025-03-21T14:30:00+00:00": 162.8699951171875,
      "2025-03-21T15:30:00+00:00": 163.63499450683594,
      "2025-03-21T16:30:00+00:00": 163.36000061035156,
      "2025-03-21T17:30:00+00:00": 163.1999969482422,
      "2025-03-21T18:30:00+00:00": 162.91000366210938,
      "2025-03-21T19:30:00+00:00": 163.0050048828125
    },
    "sentiment": 0.7472982406616211
  },
  {
    "title": "Top Midday Stories: Boeing Wins Multibillion Dollar Contract to Build Fighter Jet; FedEx Shares Fall on Earnings Miss, Downbeat Guidance",
    "published": 1742572897,
    "day_prices": {
      "2025-03-21T13:30:00+00:00": 163.0,
      "2025-03-21T14:30:00+00:00": 162.8699951171875,
      "2025-03-21T15:30:00+00:00": 163.63499450683594,
      "2025-03-21T16:30:00+00:00": 163.36000061035156,
      "2025-03-21T17:30:00+00:00": 163.1999969482422,
      "2025-03-21T18:30:00+00:00": 162.91000366210938,
      "2025-03-21T19:30:00+00:00": 163.0050048828125
    },
    "sentiment": 0.9660735726356506
  },
  {
    "title": "Johnson & Johnson Boosts Planned US Investment to More Than $55 Billion",
    "published": 1742569486,
    "day_prices": {
      "2025-03-21T13:30:00+00:00": 163.0,
      "2025-03-21T14:30:00+00:00": 162.8699951171875,
      "2025-03-21T15:30:00+00:00": 163.63499450683594,
      "2025-03-21T16:30:00+00:00": 163.36000061035156,
      "2025-03-21T17:30:00+00:00": 163.1999969482422,
      "2025-03-21T18:30:00+00:00": 162.91000366210938,
      "2025-03-21T19:30:00+00:00": 163.0050048828125
    },
    "sentiment": 0.9475088715553284
  },
  {
    "title": "2025 Dividend Kings: Strong Run Continues",
    "published": 1742561991,
    "day_prices": {
      "2025-03-21T13:30:00+00:00": 163.0,
      "2025-03-21T14:30:00+00:00": 162.8699951171875,
      "2025-03-21T15:30:00+00:00": 163.63499450683594,
      "2025-03-21T16:30:00+00:00": 163.36000061035156,
      "2025-03-21T17:30:00+00:00": 163.1999969482422,
      "2025-03-21T18:30:00+00:00": 162.91000366210938,
      "2025-03-21T19:30:00+00:00": 163.0050048828125
    },
    "sentiment": 0.9449778199195862
  },
  {
    "title": "J&J's Tremfya Gets FDA Nod for 2nd IBD Condition Crohn's Disease",
    "published": 1742560080,
    "day_prices": {
      "2025-03-21T13:30:00+00:00": 163.0,
      "2025-03-21T14:30:00+00:00": 162.8699951171875,
      "2025-03-21T15:30:00+00:00": 163.63499450683594,
      "2025-03-21T16:30:00+00:00": 163.36000061035156,
      "2025-03-21T17:30:00+00:00": 163.1999969482422,
      "2025-03-21T18:30:00+00:00": 162.91000366210938,
      "2025-03-21T19:30:00+00:00": 163.0050048828125
    },
    "sentiment": 0.8703896403312683
  },
  {
    "title": "Johnson & Johnson plans $55 billion in US investments over the next four years",
    "published": 1742557296,
    "day_prices": {
      "2025-03-21T13:30:00+00:00": 163.0,
      "2025-03-21T14:30:00+00:00": 162.8699951171875,
      "2025-03-21T15:30:00+00:00": 163.63499450683594,
      "2025-03-21T16:30:00+00:00": 163.36000061035156,
      "2025-03-21T17:30:00+00:00": 163.1999969482422,
      "2025-03-21T18:30:00+00:00": 162.91000366210938,
      "2025-03-21T19:30:00+00:00": 163.0050048828125
    },
    "sentiment": 0.8602873682975769
  },
  {
    "title": "J&J boosts US manufacturing as big pharma reshores",
    "published": 1742551733,
    "day_prices": {
      "2025-03-21T13:30:00+00:00": 163.0,
      "2025-03-21T14:30:00+00:00": 162.8699951171875,
      "2025-03-21T15:30:00+00:00": 163.63499450683594,
      "2025-03-21T16:30:00+00:00": 163.36000061035156,
      "2025-03-21T17:30:00+00:00": 163.1999969482422,
      "2025-03-21T18:30:00+00:00": 162.91000366210938,
      "2025-03-21T19:30:00+00:00": 163.0050048828125
    },
    "sentiment": 0.9403107166290283
  },
  {
    "title": "FDA approves Johnson & Johnson\u2019s Tremfya to treat Crohn\u2019s disease",
    "published": 1742548828,
    "day_prices": {
      "2025-03-21T13:30:00+00:00": 163.0,
      "2025-03-21T14:30:00+00:00": 162.8699951171875,
      "2025-03-21T15:30:00+00:00": 163.63499450683594,
      "2025-03-21T16:30:00+00:00": 163.36000061035156,
      "2025-03-21T17:30:00+00:00": 163.1999969482422,
      "2025-03-21T18:30:00+00:00": 162.91000366210938,
      "2025-03-21T19:30:00+00:00": 163.0050048828125
    },
    "sentiment": 0.6346912980079651
  },
  {
    "title": "PBMs Are Becoming Legal Risks For Employers",
    "published": 1742544615,
    "day_prices": {
      "2025-03-21T13:30:00+00:00": 163.0,
      "2025-03-21T14:30:00+00:00": 162.8699951171875,
      "2025-03-21T15:30:00+00:00": 163.63499450683594,
      "2025-03-21T16:30:00+00:00": 163.36000061035156,
      "2025-03-21T17:30:00+00:00": 163.1999969482422,
      "2025-03-21T18:30:00+00:00": 162.91000366210938,
      "2025-03-21T19:30:00+00:00": 163.0050048828125
    },
    "sentiment": 0.7602519392967224
  },
  {
    "title": "J&J plans to invest more than $55 billion in US over next four years",
    "published": 1742537533,
    "day_prices": {
      "2025-03-21T13:30:00+00:00": 163.0,
      "2025-03-21T14:30:00+00:00": 162.8699951171875,
      "2025-03-21T15:30:00+00:00": 163.63499450683594,
      "2025-03-21T16:30:00+00:00": 163.36000061035156,
      "2025-03-21T17:30:00+00:00": 163.1999969482422,
      "2025-03-21T18:30:00+00:00": 162.91000366210938,
      "2025-03-21T19:30:00+00:00": 163.0050048828125
    },
    "sentiment": 0.7682732939720154
  },
  {
    "title": "U.S. FDA approves TREMFYA\u00ae (guselkumab), the first and only IL-23 inhibitor offering both subcutaneous and intravenous induction options, for adult patients with moderately to severely active Crohn's disease",
    "published": 1742508720,
    "day_prices": {
      "2025-03-20T13:30:00+00:00": 163.0,
      "2025-03-20T14:30:00+00:00": 163.0500030517578,
      "2025-03-20T15:30:00+00:00": 162.00999450683594,
      "2025-03-20T16:30:00+00:00": 162.72999572753906,
      "2025-03-20T17:30:00+00:00": 162.71170043945312,
      "2025-03-20T18:30:00+00:00": 162.61500549316406,
      "2025-03-20T19:30:00+00:00": 162.8000030517578
    },
    "sentiment": 0.9020929336547852
  },
  {
    "title": "RYBREVANT\u00ae (amivantamab-vmjw) plus LAZCLUZE\u2122 (lazertinib) significantly outperforms standard of care in first-line EGFR-mutated lung cancer with compelling new data at ELCC 2025",
    "published": 1742472000,
    "day_prices": {
      "2025-03-20T13:30:00+00:00": 163.0,
      "2025-03-20T14:30:00+00:00": 163.0500030517578,
      "2025-03-20T15:30:00+00:00": 162.00999450683594,
      "2025-03-20T16:30:00+00:00": 162.72999572753906,
      "2025-03-20T17:30:00+00:00": 162.71170043945312,
      "2025-03-20T18:30:00+00:00": 162.61500549316406,
      "2025-03-20T19:30:00+00:00": 162.8000030517578
    },
    "sentiment": 0.9516430497169495
  },
  {
    "title": "My Dividend Stock Portfolio: New February Dividend Record - 100 Holdings With 11 Buys",
    "published": 1742463648,
    "day_prices": {
      "2025-03-20T13:30:00+00:00": 163.0,
      "2025-03-20T14:30:00+00:00": 163.0500030517578,
      "2025-03-20T15:30:00+00:00": 162.00999450683594,
      "2025-03-20T16:30:00+00:00": 162.72999572753906,
      "2025-03-20T17:30:00+00:00": 162.71170043945312,
      "2025-03-20T18:30:00+00:00": 162.61500549316406,
      "2025-03-20T19:30:00+00:00": 162.8000030517578
    },
    "sentiment": 0.8375982642173767
  },
  {
    "title": "The Zacks Analyst Blog Highlights Visa, Johnson & Johnson, Thermo Fisher and AMREP",
    "published": 1742374800,
    "day_prices": {
      "2025-03-19T13:30:00+00:00": 163.97000122070312,
      "2025-03-19T14:30:00+00:00": 163.30999755859375,
      "2025-03-19T15:30:00+00:00": 162.93499755859375,
      "2025-03-19T16:30:00+00:00": 163.0850067138672,
      "2025-03-19T17:30:00+00:00": 162.5500030517578,
      "2025-03-19T18:30:00+00:00": 162.3000030517578,
      "2025-03-19T19:30:00+00:00": 163.22000122070312
    },
    "sentiment": 0.939963161945343
  },
  {
    "title": "Widely used drugs on US imports list from Europe",
    "published": 1742302715,
    "day_prices": {
      "2025-03-18T13:30:00+00:00": 163.44000244140625,
      "2025-03-18T14:30:00+00:00": 164.36500549316406,
      "2025-03-18T15:30:00+00:00": 164.16000366210938,
      "2025-03-18T16:30:00+00:00": 163.99000549316406,
      "2025-03-18T17:30:00+00:00": 163.69500732421875,
      "2025-03-18T18:30:00+00:00": 164.00999450683594,
      "2025-03-18T19:30:00+00:00": 164.1649932861328
    },
    "sentiment": 0.9096798300743103
  },
  {
    "title": "Why Organon Is A Top Pick For Income Investors",
    "published": 1742252303,
    "day_prices": {
      "2025-03-17T13:30:00+00:00": 162.41000366210938,
      "2025-03-17T14:30:00+00:00": 163.22000122070312,
      "2025-03-17T15:30:00+00:00": 162.69000244140625,
      "2025-03-17T16:30:00+00:00": 163.07000732421875,
      "2025-03-17T17:30:00+00:00": 163.00999450683594,
      "2025-03-17T18:30:00+00:00": 163.10499572753906,
      "2025-03-17T19:30:00+00:00": 162.89999389648438
    },
    "sentiment": 0.9111111164093018
  },
  {
    "title": "Johnson & Johnson (JNJ) Could Be a Great Choice",
    "published": 1741967105,
    "day_prices": {
      "2025-03-14T13:30:00+00:00": 162.1199951171875,
      "2025-03-14T14:30:00+00:00": 162.1999969482422,
      "2025-03-14T15:30:00+00:00": 162.07000732421875,
      "2025-03-14T16:30:00+00:00": 162.30999755859375,
      "2025-03-14T17:30:00+00:00": 162.64999389648438,
      "2025-03-14T18:30:00+00:00": 162.64999389648438,
      "2025-03-14T19:30:00+00:00": 162.6199951171875
    },
    "sentiment": 0.6627047657966614
  },
  {
    "title": "Hostage to Legal Decisions \u2013 Here\u2019s Why Jim Cramer Gave Up on Johnson & Johnson (JNJ)",
    "published": 1741962391,
    "day_prices": {
      "2025-03-14T13:30:00+00:00": 162.1199951171875,
      "2025-03-14T14:30:00+00:00": 162.1999969482422,
      "2025-03-14T15:30:00+00:00": 162.07000732421875,
      "2025-03-14T16:30:00+00:00": 162.30999755859375,
      "2025-03-14T17:30:00+00:00": 162.64999389648438,
      "2025-03-14T18:30:00+00:00": 162.64999389648438,
      "2025-03-14T19:30:00+00:00": 162.6199951171875
    },
    "sentiment": 0.9236858487129211
  },
  {
    "title": "Big Pharma Walked Away From Mental Health. Why Some Are Coming Back.",
    "published": 1741944600,
    "day_prices": {
      "2025-03-14T13:30:00+00:00": 162.1199951171875,
      "2025-03-14T14:30:00+00:00": 162.1999969482422,
      "2025-03-14T15:30:00+00:00": 162.07000732421875,
      "2025-03-14T16:30:00+00:00": 162.30999755859375,
      "2025-03-14T17:30:00+00:00": 162.64999389648438,
      "2025-03-14T18:30:00+00:00": 162.64999389648438,
      "2025-03-14T19:30:00+00:00": 162.6199951171875
    },
    "sentiment": 0.8314618468284607
  },
  {
    "title": "Honeywell's Planned Spinoff And What It Means Amid Macro Volatility",
    "published": 1741924800,
    "day_prices": {
      "2025-03-14T13:30:00+00:00": 162.1199951171875,
      "2025-03-14T14:30:00+00:00": 162.1999969482422,
      "2025-03-14T15:30:00+00:00": 162.07000732421875,
      "2025-03-14T16:30:00+00:00": 162.30999755859375,
      "2025-03-14T17:30:00+00:00": 162.64999389648438,
      "2025-03-14T18:30:00+00:00": 162.64999389648438,
      "2025-03-14T19:30:00+00:00": 162.6199951171875
    },
    "sentiment": 0.9220299124717712
  },
  {
    "title": "Johnson & Johnson (NYSE:JNJ) Faces Shareholder Activism Over Human Rights and Executive Pay Proposals",
    "published": 1741886924,
    "day_prices": {
      "2025-03-13T13:30:00+00:00": 163.42999267578125,
      "2025-03-13T14:30:00+00:00": 163.49000549316406,
      "2025-03-13T15:30:00+00:00": 163.27000427246094,
      "2025-03-13T16:30:00+00:00": 162.83999633789062,
      "2025-03-13T17:30:00+00:00": 163.16000366210938,
      "2025-03-13T18:30:00+00:00": 163.0500030517578,
      "2025-03-13T19:30:00+00:00": 162.8000030517578
    },
    "sentiment": 0.9561622142791748
  },
  {
    "title": "J&J\u2019s Monarch robot wins FDA nod for AI software update",
    "published": 1741860000,
    "day_prices": {
      "2025-03-13T13:30:00+00:00": 163.42999267578125,
      "2025-03-13T14:30:00+00:00": 163.49000549316406,
      "2025-03-13T15:30:00+00:00": 163.27000427246094,
      "2025-03-13T16:30:00+00:00": 162.83999633789062,
      "2025-03-13T17:30:00+00:00": 163.16000366210938,
      "2025-03-13T18:30:00+00:00": 163.0500030517578,
      "2025-03-13T19:30:00+00:00": 162.8000030517578
    },
    "sentiment": 0.8147865533828735
  },
  {
    "title": "Johnson & Johnson : 2025 Proxy Statement and additional solicitation materials (Johnson Johnson 2025 Proxy)",
    "published": 1741788012,
    "day_prices": {
      "2025-03-12T13:30:00+00:00": 163.72999572753906,
      "2025-03-12T14:30:00+00:00": 163.1199951171875,
      "2025-03-12T15:30:00+00:00": 162.8300018310547,
      "2025-03-12T16:30:00+00:00": 163.05999755859375,
      "2025-03-12T17:30:00+00:00": 162.94000244140625,
      "2025-03-12T18:30:00+00:00": 162.9499969482422,
      "2025-03-12T19:30:00+00:00": 162.69000244140625
    },
    "sentiment": 0.9488735795021057
  },
  {
    "title": "Johnson & Johnson (JNJ): Among Dobermans of the Dow to Buy",
    "published": 1741787233,
    "day_prices": {
      "2025-03-12T13:30:00+00:00": 163.72999572753906,
      "2025-03-12T14:30:00+00:00": 163.1199951171875,
      "2025-03-12T15:30:00+00:00": 162.8300018310547,
      "2025-03-12T16:30:00+00:00": 163.05999755859375,
      "2025-03-12T17:30:00+00:00": 162.94000244140625,
      "2025-03-12T18:30:00+00:00": 162.9499969482422,
      "2025-03-12T19:30:00+00:00": 162.69000244140625
    },
    "sentiment": 0.845208466053009
  },
  {
    "title": "Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know",
    "published": 1741784411,
    "day_prices": {
      "2025-03-12T13:30:00+00:00": 163.72999572753906,
      "2025-03-12T14:30:00+00:00": 163.1199951171875,
      "2025-03-12T15:30:00+00:00": 162.8300018310547,
      "2025-03-12T16:30:00+00:00": 163.05999755859375,
      "2025-03-12T17:30:00+00:00": 162.94000244140625,
      "2025-03-12T18:30:00+00:00": 162.9499969482422,
      "2025-03-12T19:30:00+00:00": 162.69000244140625
    },
    "sentiment": 0.9064252972602844
  },
  {
    "title": "Fidelity Select Health Care Portfolio Q4 2024 Review",
    "published": 1741773660,
    "day_prices": {
      "2025-03-12T13:30:00+00:00": 163.72999572753906,
      "2025-03-12T14:30:00+00:00": 163.1199951171875,
      "2025-03-12T15:30:00+00:00": 162.8300018310547,
      "2025-03-12T16:30:00+00:00": 163.05999755859375,
      "2025-03-12T17:30:00+00:00": 162.94000244140625,
      "2025-03-12T18:30:00+00:00": 162.9499969482422,
      "2025-03-12T19:30:00+00:00": 162.69000244140625
    },
    "sentiment": 0.9469819664955139
  },
  {
    "title": "Johnson & Johnson (NYSE:JNJ) Reports Positive Phase 2b Trial Results For Ulcerative Colitis Treatment",
    "published": 1741714590,
    "day_prices": {
      "2025-03-11T13:30:00+00:00": 167.1999969482422,
      "2025-03-11T14:30:00+00:00": 166.5500030517578,
      "2025-03-11T15:30:00+00:00": 165.4199981689453,
      "2025-03-11T16:30:00+00:00": 165.47500610351562,
      "2025-03-11T17:30:00+00:00": 165.6199951171875,
      "2025-03-11T18:30:00+00:00": 165.61000061035156,
      "2025-03-11T19:30:00+00:00": 166.0601043701172
    },
    "sentiment": 0.9447810649871826
  },
  {
    "title": "PTGX Up as J&J-Partnered Drug Meets Goal in Ulcerative Colitis Study",
    "published": 1741709700,
    "day_prices": {
      "2025-03-11T13:30:00+00:00": 167.1999969482422,
      "2025-03-11T14:30:00+00:00": 166.5500030517578,
      "2025-03-11T15:30:00+00:00": 165.4199981689453,
      "2025-03-11T16:30:00+00:00": 165.47500610351562,
      "2025-03-11T17:30:00+00:00": 165.6199951171875,
      "2025-03-11T18:30:00+00:00": 165.61000061035156,
      "2025-03-11T19:30:00+00:00": 166.0601043701172
    },
    "sentiment": 0.9228276014328003
  },
  {
    "title": "Protagonist Therapeutics: Much More Than Rusfertide In Place To Carry It",
    "published": 1741708809,
    "day_prices": {
      "2025-03-11T13:30:00+00:00": 167.1999969482422,
      "2025-03-11T14:30:00+00:00": 166.5500030517578,
      "2025-03-11T15:30:00+00:00": 165.4199981689453,
      "2025-03-11T16:30:00+00:00": 165.47500610351562,
      "2025-03-11T17:30:00+00:00": 165.6199951171875,
      "2025-03-11T18:30:00+00:00": 165.61000061035156,
      "2025-03-11T19:30:00+00:00": 166.0601043701172
    },
    "sentiment": 0.735649585723877
  },
  {
    "title": "Protagonist Therapeutics Soars as Icotrokinra Drives Breakthrough Success",
    "published": 1741699755,
    "day_prices": {
      "2025-03-11T13:30:00+00:00": 167.1999969482422,
      "2025-03-11T14:30:00+00:00": 166.5500030517578,
      "2025-03-11T15:30:00+00:00": 165.4199981689453,
      "2025-03-11T16:30:00+00:00": 165.47500610351562,
      "2025-03-11T17:30:00+00:00": 165.6199951171875,
      "2025-03-11T18:30:00+00:00": 165.61000061035156,
      "2025-03-11T19:30:00+00:00": 166.0601043701172
    },
    "sentiment": 0.7433111071586609
  },
  {
    "title": "J&J and Protagonist\u2019s icotrokinra scores in Phase IIb UC study",
    "published": 1741696667,
    "day_prices": {
      "2025-03-11T13:30:00+00:00": 167.1999969482422,
      "2025-03-11T14:30:00+00:00": 166.5500030517578,
      "2025-03-11T15:30:00+00:00": 165.4199981689453,
      "2025-03-11T16:30:00+00:00": 165.47500610351562,
      "2025-03-11T17:30:00+00:00": 165.6199951171875,
      "2025-03-11T18:30:00+00:00": 165.61000061035156,
      "2025-03-11T19:30:00+00:00": 166.0601043701172
    },
    "sentiment": 0.7794142365455627
  },
  {
    "title": "Investigational plaque psoriasis treatments show promise in late-stage trials",
    "published": 1741683739,
    "day_prices": {
      "2025-03-11T13:30:00+00:00": 167.1999969482422,
      "2025-03-11T14:30:00+00:00": 166.5500030517578,
      "2025-03-11T15:30:00+00:00": 165.4199981689453,
      "2025-03-11T16:30:00+00:00": 165.47500610351562,
      "2025-03-11T17:30:00+00:00": 165.6199951171875,
      "2025-03-11T18:30:00+00:00": 165.61000061035156,
      "2025-03-11T19:30:00+00:00": 166.0601043701172
    },
    "sentiment": 0.9311613440513611
  },
  {
    "title": "Johnson & Johnson - Icotrokinra results show potential to set a new standard of treatment in plaque psoriasis",
    "published": 1741610360,
    "day_prices": {
      "2025-03-10T13:30:00+00:00": 167.47999572753906,
      "2025-03-10T14:30:00+00:00": 168.5500030517578,
      "2025-03-10T15:30:00+00:00": 168.91000366210938,
      "2025-03-10T16:30:00+00:00": 168.7899932861328,
      "2025-03-10T17:30:00+00:00": 168.91000366210938,
      "2025-03-10T18:30:00+00:00": 168.80499267578125,
      "2025-03-10T19:30:00+00:00": 167.55999755859375
    },
    "sentiment": 0.9118908643722534
  },
  {
    "title": "Genmab Stops Blood Cancer Treatment Development After J&J Won't License It",
    "published": 1741603380,
    "day_prices": {
      "2025-03-10T13:30:00+00:00": 167.47999572753906,
      "2025-03-10T14:30:00+00:00": 168.5500030517578,
      "2025-03-10T15:30:00+00:00": 168.91000366210938,
      "2025-03-10T16:30:00+00:00": 168.7899932861328,
      "2025-03-10T17:30:00+00:00": 168.91000366210938,
      "2025-03-10T18:30:00+00:00": 168.80499267578125,
      "2025-03-10T19:30:00+00:00": 167.55999755859375
    },
    "sentiment": 0.8975165486335754
  },
  {
    "title": "Health Canada authorizes LAZCLUZE\u00ae (lazertinib) in combination with RYBREVANT\u00ae (amivantamab) as a first-line chemotherapy-free treatment for patients with EGFR-mutated advanced lung cancer",
    "published": 1741595495,
    "day_prices": {
      "2025-03-10T13:30:00+00:00": 167.47999572753906,
      "2025-03-10T14:30:00+00:00": 168.5500030517578,
      "2025-03-10T15:30:00+00:00": 168.91000366210938,
      "2025-03-10T16:30:00+00:00": 168.7899932861328,
      "2025-03-10T17:30:00+00:00": 168.91000366210938,
      "2025-03-10T18:30:00+00:00": 168.80499267578125,
      "2025-03-10T19:30:00+00:00": 167.55999755859375
    },
    "sentiment": 0.8557984232902527
  },
  {
    "title": "Intuitive Surgical: Getting Closed To Its Fair Value",
    "published": 1741523603,
    "day_prices": {},
    "sentiment": 0.75324946641922
  },
  {
    "title": "Johnson & Johnson Statement on VENTURA Program",
    "published": 1741344740,
    "day_prices": {
      "2025-03-07T14:30:00+00:00": 165.1300048828125,
      "2025-03-07T15:30:00+00:00": 167.4600067138672,
      "2025-03-07T16:30:00+00:00": 167.64999389648438,
      "2025-03-07T17:30:00+00:00": 167.8800048828125,
      "2025-03-07T18:30:00+00:00": 167.72999572753906,
      "2025-03-07T19:30:00+00:00": 167.24000549316406,
      "2025-03-07T20:30:00+00:00": 167.22000122070312
    },
    "sentiment": 0.913726806640625
  },
  {
    "title": "Finance Executives Seek Stability Amid Erratic Tariff Shifts",
    "published": 1741291200,
    "day_prices": {
      "2025-03-06T14:30:00+00:00": 165.0,
      "2025-03-06T15:30:00+00:00": 163.80999755859375,
      "2025-03-06T16:30:00+00:00": 164.72000122070312,
      "2025-03-06T17:30:00+00:00": 164.58999633789062,
      "2025-03-06T18:30:00+00:00": 164.69500732421875,
      "2025-03-06T19:30:00+00:00": 165.08999633789062,
      "2025-03-06T20:30:00+00:00": 165.86959838867188
    },
    "sentiment": 0.714271068572998
  },
  {
    "title": "10 Dividend Aristocrat Bargains To Help You SWAN During This Trade War Turmoil",
    "published": 1741244400,
    "day_prices": {
      "2025-03-06T14:30:00+00:00": 165.0,
      "2025-03-06T15:30:00+00:00": 163.80999755859375,
      "2025-03-06T16:30:00+00:00": 164.72000122070312,
      "2025-03-06T17:30:00+00:00": 164.58999633789062,
      "2025-03-06T18:30:00+00:00": 164.69500732421875,
      "2025-03-06T19:30:00+00:00": 165.08999633789062,
      "2025-03-06T20:30:00+00:00": 165.86959838867188
    },
    "sentiment": 0.84100741147995
  },
  {
    "title": "Johnson & Johnson and 4 Other Biopharmaceutical Stocks That Might Be Ready to Break Out",
    "published": 1741189140,
    "day_prices": {
      "2025-03-05T14:30:00+00:00": 164.50999450683594,
      "2025-03-05T15:30:00+00:00": 164.1300048828125,
      "2025-03-05T16:30:00+00:00": 164.63999938964844,
      "2025-03-05T17:30:00+00:00": 165.38999938964844,
      "2025-03-05T18:30:00+00:00": 164.8300018310547,
      "2025-03-05T19:30:00+00:00": 165.27999877929688,
      "2025-03-05T20:30:00+00:00": 165.13999938964844
    },
    "sentiment": 0.6149036884307861
  },
  {
    "title": "Johnson & Johnson: No More Tears, Just Gains In Intra-Cellular Acquisition",
    "published": 1741173872,
    "day_prices": {
      "2025-03-05T14:30:00+00:00": 164.50999450683594,
      "2025-03-05T15:30:00+00:00": 164.1300048828125,
      "2025-03-05T16:30:00+00:00": 164.63999938964844,
      "2025-03-05T17:30:00+00:00": 165.38999938964844,
      "2025-03-05T18:30:00+00:00": 164.8300018310547,
      "2025-03-05T19:30:00+00:00": 165.27999877929688,
      "2025-03-05T20:30:00+00:00": 165.13999938964844
    },
    "sentiment": 0.8795713186264038
  },
  {
    "title": "$20 Billion Club: For The Largest Corporate DB Plans, Maximizing Returns Is Not The Goal",
    "published": 1741105440,
    "day_prices": {
      "2025-03-04T14:30:00+00:00": 168.0800018310547,
      "2025-03-04T15:30:00+00:00": 169.77999877929688,
      "2025-03-04T16:30:00+00:00": 168.42999267578125,
      "2025-03-04T17:30:00+00:00": 166.97000122070312,
      "2025-03-04T18:30:00+00:00": 166.4355010986328,
      "2025-03-04T19:30:00+00:00": 165.875,
      "2025-03-04T20:30:00+00:00": 166.1300048828125
    },
    "sentiment": 0.8921986818313599
  },
  {
    "title": "Johnson & Johnson (JNJ) Presents at 45th Annual TD Cowen Healthcare Conference (Transcript)",
    "published": 1741101305,
    "day_prices": {
      "2025-03-04T14:30:00+00:00": 168.0800018310547,
      "2025-03-04T15:30:00+00:00": 169.77999877929688,
      "2025-03-04T16:30:00+00:00": 168.42999267578125,
      "2025-03-04T17:30:00+00:00": 166.97000122070312,
      "2025-03-04T18:30:00+00:00": 166.4355010986328,
      "2025-03-04T19:30:00+00:00": 165.875,
      "2025-03-04T20:30:00+00:00": 166.1300048828125
    },
    "sentiment": 0.9279226064682007
  },
  {
    "title": "Johnson & Johnson : Shockwave Medical Launches Novel Forward Intravascular Lithotripsy Platform in U.S. to Transform Treatment of Difficult to Cross Calcified Lesions",
    "published": 1741076345,
    "day_prices": {
      "2025-03-04T14:30:00+00:00": 168.0800018310547,
      "2025-03-04T15:30:00+00:00": 169.77999877929688,
      "2025-03-04T16:30:00+00:00": 168.42999267578125,
      "2025-03-04T17:30:00+00:00": 166.97000122070312,
      "2025-03-04T18:30:00+00:00": 166.4355010986328,
      "2025-03-04T19:30:00+00:00": 165.875,
      "2025-03-04T20:30:00+00:00": 166.1300048828125
    },
    "sentiment": 0.7940694093704224
  },
  {
    "title": "Johnson & Johnson's DARZALEX subcutaneous-based regimen receives positive CHMP opinion for patients with newly diagnosed multiple myeloma, regardless of transplant eligibility",
    "published": 1740999560,
    "day_prices": {
      "2025-03-03T14:30:00+00:00": 164.9600067138672,
      "2025-03-03T15:30:00+00:00": 166.48500061035156,
      "2025-03-03T16:30:00+00:00": 166.55999755859375,
      "2025-03-03T17:30:00+00:00": 166.60499572753906,
      "2025-03-03T18:30:00+00:00": 166.4499969482422,
      "2025-03-03T19:30:00+00:00": 166.19000244140625,
      "2025-03-03T20:30:00+00:00": 166.6199951171875
    },
    "sentiment": 0.9504820108413696
  },
  {
    "title": "5 Relatively Secure And Cheap Dividend Stocks, Yields Upto 8% (March 2025)",
    "published": 1740816000,
    "day_prices": {},
    "sentiment": 0.8670790195465088
  }
]